• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 0.16% Nasdaq Down 0.13%

    CytRx Corporation (CYTR)

    -NasdaqCM
    4.00 Up 0.07(1.78%) 4:00PM EDT
    |After Hours : 4.00 0.00 (0.00%) 4:32PM EDT
    Add to Portfolio
    Prev Close:3.93
    Open:3.90
    Bid:3.72 x 5000
    Ask:4.54 x 200
    1y Target Est:8.50
    Beta:0.97
    Earnings Date:Aug 4 - Aug 10 (Est.)
    Day's Range:3.90 - 4.11
    52wk Range:2.08 - 5.46
    Volume:392,570
    Avg Vol (3m):1,186,420
    Market Cap:222.89M
    P/E (ttm):N/A
    EPS (ttm):-0.94
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Comparison

    Symbol% ChgMkt Cap
    CYTRUp 1.78%222.89M
    LLYDown 1.33%82.55B
    NVSDown 0.33%249.15B
    SNYUp 0.99%130.17B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):2,189.87
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :-1.12
    Quarterly EPS Est (Jun-15) :-0.27
    Mean Recommendation*:1.5
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    CytRx Corporation operates as a biopharmaceutical research and development company specializing in oncology. The company’s product candidate is aldoxorubicin, which is in Phase III clinical trial as a therapy for patients with soft tissue sar... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback